Aidoc Medical

New York, NY, USA (with a significant presence in Tel Aviv, Israel) All United States companies → — Founded 2016

Clinical AI Platform Imaging AI Specialist

Cardiology Emergency Medicine General Surgery Neurology

Cardiology AI Clinical Decision Support & Reference Radiology & Imaging AI

Series E — $420M

Claim this company

Products

BriefCase-Triage

Aidoc Medical

Cardiology AI

Aidoc's BriefCase-Triage is an FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images.

Enterprise

BriefCase-Quantification

Aidoc Medical

Cardiology AI

Aidoc's BriefCase-Quantification is an FDA-cleared AI tool for radiologists, providing automated abdominal aortic diameter measurements from CT scans to assist clinical decision-making and streamline workflows.

Contact for pricing

BriefCase

Aidoc Medical

Clinical Decision Support & Reference

Aidoc's BriefCase is an FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.

Enterprise

See all 3 products →

About Aidoc Medical

Aidoc Medical is a pioneering healthcare AI company that develops computer-aided triage and notification systems to significantly enhance efficiency and patient outcomes across various medical specialties. Their core offering, the “Always-on AI” platform (aiOS™), continuously analyzes medical imaging data in the background, identifying urgent findings and prioritizing critical cases for radiologists and care teams. This proactive approach is designed to reduce diagnostic errors, alleviate cognitive overload, and expedite patient care by providing real-time insights and fostering seamless communication among multidisciplinary teams.

The company boasts a comprehensive suite of numerous FDA-cleared AI algorithms that cover a broad spectrum of pathologies, including intracranial hemorrhage, pulmonary embolism, stroke, cervical fracture, intra-abdominal free gas, brain aneurysm, aortic dissection, and vertebral compression fractures. Aidoc’s solutions are engineered for deep integration with existing hospital IT infrastructure, such as EHR, PACS, scheduling, and reporting systems, aiming to streamline workflows, automate repetitive tasks, and improve care coordination from initial diagnosis through patient follow-up. Aidoc is also actively expanding its clinical AI solutions into new areas like oncology and cardiovascular disease, leveraging its clinical-grade foundation model, CARE™, to further assist physicians in complex clinical decision-making.

Focus Areas

Radiology Cardiology Neurovascular Vascular Oncology (planned expansion) AI-powered triage clinical decision support care coordination patient management medical imaging analysis deep learning foundation models

Business Intelligence

Key Investors	General Catalyst, Square Peg, NVentures (NVIDIA's venture arm), Hartford HealthCare, Mercy, Sutter Health, WellSpan Health, TLV Partners, Magma Venture Partners, Emerge Ventures, Alpha Intelligence Capital (AIC), TCV, CDIB Capital, AWS (strategic partner)
Partnerships	Mayo Clinic Platform, Cercare Medical, Circle CVI, Novant Health, AdventHealth, Advocate Health, Sutter Health, NVIDIA, AWS
Technology	aiOS™ enterprise platform, CARE™ (Clinical AI Reasoning Engine) foundation model, cloud-native (utilizing AWS services like Amazon EC2, S3, RDS), Always-on AI
FDA Clearances	20+ cleared products (estimated)

What Physicians Need to Know

Specialized Clinical AI Solutions

Aidoc offers a comprehensive suite of AI solutions across multiple medical specialties, including Radiology, Cardiology, Neurovascular, and Vascular care. They provide AI-powered triage, clinical decision support, care coordination, patient management, and medical imaging analysis. Aidoc is also planning expansion into Oncology.

AI-Powered Triage & Prioritization

Their solutions are designed for real-time analysis of medical imaging to flag acute abnormalities, prioritize life-threatening cases, and expedite patient treatment. This includes comprehensive triage for a wide range of acute findings, such as intracranial hemorrhage, pulmonary embolism, and large vessel occlusions.

Clinical Decision Support & Care Coordination

Aidoc's platform provides real-time insights, connecting care teams across specialties and departments to unify the patient journey. It mobilizes specialists in real time, accelerating communication and supporting faster treatment decisions, and also assists with patient capture and follow-up management.

Advanced Medical Imaging Analysis

Leveraging deep learning and foundation models, Aidoc's AI analyzes vast quantities of imaging data to detect subtle anomalies and incidental findings, even in scans not specifically ordered for those conditions. This enhances disease identification and improves awareness of unexpected findings.

Proprietary AI Operating System (aiOSu2122)

Aidoc's aiOSu2122 is an enterprise-level platform that ingests messy data, orchestrates intelligent workflows, monitors performance in real-time, and drives measurable outcomes from diagnosis to follow-up. It acts as a unified, intelligent clinical layer that integrates both imaging and EHR data.

CAREu2122 Foundation Model

CAREu2122 (Clinical AI Reasoning Engine) is Aidoc's clinical-grade foundation model, trained on real-world, multimodal data (imaging, text, EHR, labs, vitals). It powers FDA-cleared applications, enabling faster development of new indications and delivering higher accuracy and broader coverage than single-modality models.

Seamless Integration & Workflow Embedding

The Aidoc system is built to integrate seamlessly into existing clinical operations and IT infrastructure, across sites, vendors, and specialties, without requiring clinicians to navigate new software or change established practices.

Focus on Acute Clinical Use Cases & R&D

Aidoc's early success stemmed from its focus on acute, often life-or-death clinical use cases, allowing for clear demonstration of value. The company maintains an R&D-first culture, emphasizing research and development to build highly accurate AI tools that integrate smoothly into complex healthcare environments.

Physician Tip

For physicians, Aidoc's solutions act as an 'always-on' AI partner that enhances situational awareness and reduces cognitive overload, allowing more capacity for complex decisions and direct patient care. The system provides real-time notifications for critical findings, prioritizes urgent cases, and streamlines workflows, leading to faster turnaround times (up to 98% faster radiology TAT) and improved patient outcomes, including reduced length of stay in ICUs. Its ability to detect incidental findings and integrate with existing systems means less disruption and more comprehensive insights without adding complexity to daily routines. The platform also supports patient follow-up, helping to prevent patients from being lost to care.

Aidoc's aiOSu2122 is designed as a unified AI operating system that integrates seamlessly with existing imaging infrastructure (PACS, EHR, scheduling systems) across various sites and vendors. It supports both Aidoc's proprietary models and third-party AI solutions, acting as an ecosystem-driven platform to deploy and govern multiple AI applications responsibly, reducing IT complexity and allowing for continuous expansion of the AI stack without overhauling infrastructure. Aidoc also collaborates with cloud providers like AWS to enhance scalability and deployment capabilities.

At a glance

Founded 2016

HQ New York, NY, USA (with a significant presence in Tel Aviv, Israel) · United States

Team size Approximately 552 (as of March 2026)

CEO Elad Walach

Funding Series E — $420M

FDA clearances 20+ (estimated)

Products 3

Products by Aidoc Medical

3 products in the directory

BriefCase-Triage

Aidoc Medical

Cardiology AI

Aidoc's BriefCase-Triage is an FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images.

Enterprise

BriefCase-Quantification

Aidoc Medical

Cardiology AI

Contact for pricing

BriefCase

Aidoc Medical

Clinical Decision Support & Reference

Enterprise

What the Web Says

Aidoc Medical generally receives positive reviews for its AI-powered medical imaging analysis, with users highlighting its efficiency and accuracy in flagging critical findings. As an employer, reviews are mixed, with some praising the company culture and others noting areas for improvement.

Overall: Positive

Strengths

Efficiently flags critical findings in medical images, improving turnaround time.
User-friendly interface and seamless integration with existing PACS systems.
High accuracy and reliability in identifying pathologies.
Reduces radiologist workload and improves diagnostic confidence.
Positive impact on patient care by expediting critical diagnoses.
Supportive and collaborative work environment (mentioned in some employer reviews).

Limitations

Occasional false positives or irrelevant findings that require manual review.
Pricing can be a concern for smaller institutions.
Steep learning curve for some users initially.
Limited customization options for certain workflows.
Communication and management transparency issues (mentioned in some employer reviews).
Work-life balance concerns (mentioned in some employer reviews).

Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News, Reddit

Last updated: 2026-07-17

Videos

News, demos, and interviews about Aidoc Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Aidoc Medical →

View all on YouTube

Press & Coverage

Aidoc

Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports

Aidoc announced that its 'First Read' AI, designed to analyze chest radiographs and generate preliminary radiology report text, received FDA Breakthrough Device Designation. This aims to reduce reporting burdens and improve patient care amidst rising imaging demand.

2026-06

MedTech Dive

Aidoc wins breakthrough nod for AI that reads chest X-rays

Aidoc received FDA breakthrough device designation for an AI feature that analyzes chest X-rays and generates draft report text, aiming to help radiologists with increasing workloads. This system, called First Read, is expected to generate preliminary reports for over 100 pre-specified findings.

2026-06

Aidoc

Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI for Earlier, Safer Diagnoses

Aidoc secured $150 million in Series E funding led by Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Vision Fund 2, and NVentures (NVIDIA's venture capital arm). This funding will accelerate the expansion of Aidoc's CAREu2122 foundation model and enterprise AI platform to improve diagnostic efficiency.

2026-04

SiliconANGLE

Nvidia's NVentures backs $150M round for medical AI startup Aidoc

Aidoc Medical Ltd. raised $150 million in a Series C funding round led by Goldman Sachs, with NVentures (Nvidia Corp.'s startup investment arm), General Catalyst, and SoftBank Investment Advisors also participating. The company's total funding now exceeds $500 million, and it plans to use the capital to expand its aiOS platform and enhance its CARE model.

2026-04

Ctech

Aidoc raises another $150 million to advance AI in clinical decision-making

Aidoc has raised an additional $150 million to further develop its CARE foundation model, which serves as its technological core for real-time clinical decision-making. This funding comes less than a year after a similar amount was raised, bringing the company's total funding to over half a billion dollars.

2026-04

Aidoc

Aidoc Secures FDA Clearance for Healthcare's First Comprehensive Foundation Model AI

Aidoc announced FDA clearance for the healthcare industry's first comprehensive AI triage solution, which combines 11 newly cleared indications with three existing ones into a single workflow. This solution, powered by Aidoc's CAREu2122 foundation model, aims to surface critical findings earlier and reduce delays in patient flow in emergency departments.

2026-01

Radiology Business

FDA clears 11 new indications for Aidoc's triage solution

Aidoc received 11 new FDA indications for its comprehensive body CT triage solution, designed to reduce patient backlogs in emergency departments and ambulatory settings. This AI solution prioritizes scans based on initial image review, allowing acutely ill patients to receive faster care.

2026-01

PMC (PubMed Central)

A retrospective analysis comparing AIDoc and RAPIDAI in the detection of large vessel occlusions

A retrospective analysis compared the efficiency of Aidoc and RAPIDAI in diagnosing large vessel occlusions (LVOs), finding no significant difference in detection rates. The study noted the presence of false negatives in both AI algorithms, suggesting caution in their use.

2025-05

Frequently Asked Questions

How does Aidoc's AI platform enhance radiology and other imaging-based specialties?

Aidoc's AI platform, aiOSu2122, significantly enhances radiology by providing 'Always-on AI' that automatically analyzes medical images to prioritize acute findings and streamline workflows. This real-time analysis expedites diagnosis and treatment, empowering radiologists and enabling better care coordination across multidisciplinary teams.

What specific clinical use cases does Aidoc support in areas like Neurovascular, Cardiology, and future Oncology?

Aidoc offers a broad portfolio of AI solutions across Radiology, Neurovascular (e.g., stroke, brain aneurysm, spine solutions), and Cardiology (e.g., coronary artery disease, aortic care, VTE solutions). The company also has planned expansion into Oncology, with algorithms under development to assist with flagging, comparing, and volumetric measurement of lesions.

How does Aidoc ensure the accuracy, safety, and regulatory compliance of its deep learning and foundation models in clinical practice?

Aidoc ensures accuracy and safety through rigorous validation of its deep learning models and its CAREu2122 foundation model, which powers FDA-cleared applications. The company adheres to strict global security and privacy standards, including HIPAA and GDPR, and actively works with regulators to define pathways for foundation models, having received Breakthrough Device Designation for a multi-triage solution.

How does Aidoc integrate into existing PACS/EHR systems and impact care coordination and patient management workflows?

Aidoc's aiOSu2122 platform is designed for seamless integration with existing IT infrastructure, including PACS, EHR, VNA, scheduling, and communication systems, utilizing standard protocols like DICOM, HL7, and FHIR. This deep integration streamlines clinical workflows, enhances care team communication, and improves patient management by facilitating follow-up tracking and providing comprehensive clinical context.

What is the typical pricing model for Aidoc's solutions, and what kind of ROI can a healthcare organization expect?

While specific pricing models are not publicly detailed, Aidoc emphasizes a significant return on investment (ROI) for healthcare organizations, with evidence suggesting a 3-5x ROI. This value is realized through benefits such as faster time-to-treatment, reduced inpatient length-of-stay, increased patient throughput, and improved diagnostic yield.

What level of support does Aidoc provide during implementation and ongoing use, and what are their partnership strategies?

Aidoc provides comprehensive support, with its aiOSu2122 platform designed for rapid implementation, often within 2-3 weeks, and offers proactive 24/7 system monitoring. They pursue an open ecosystem strategy, partnering with third-party algorithm developers and OEMs, and make their solutions available through authorized resellers to ensure broad adoption and seamless integration.

What is Aidoc's long-term vision and company stability, especially concerning future product development and expansion into new areas?

Aidoc demonstrates strong company stability, having secured $370 million in total funding as of July 2025, with investments from major U.S. health systems. Their long-term vision centers on expanding the CAREu2122 foundation model to cover 90% of clinically relevant diseases within three years, aiming to integrate AI support into nearly every patient encounter and transform care delivery at scale.

Related Companies

Suggest an Edit →